Academic Journal

The pan-AMPK activator MK-8722 outperforms the AMPK activators SC4 and A-769662 in human endothelial cells.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: The pan-AMPK activator MK-8722 outperforms the AMPK activators SC4 and A-769662 in human endothelial cells.
Συγγραφείς: Doshi H; Institute for Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, 07745 Jena, Germany., Spengler K; Institute for Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, 07745 Jena, Germany., Siniuk K; Leibniz Institute on Aging- Fritz Lipmann Institute (FLI), 07745 Jena, Germany., Groth M; Leibniz Institute on Aging- Fritz Lipmann Institute (FLI), 07745 Jena, Germany., Heyne E; Department of Cardiothoracic Surgery, Jena University Hospital, 07747 Jena, Germany., Schwarzer M; Department of Cardiothoracic Surgery, Jena University Hospital, 07747 Jena, Germany., Godbole A; Institute for Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, 07745 Jena, Germany., Gee YS; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Australia., Baell J; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Australia.; School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China., Oakhill JS; Metabolic Signaling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy 3065, Australia.; Faculty of Health Sciences, Australian Catholic University, Melbourne 3065, Australia., Henke A; Section of Experimental Virology, Institute of Medical Microbiology, Jena University Hospital, 07745 Jena, Germany., Heller R; Institute for Molecular Cell Biology, Center for Molecular Biomedicine, Jena University Hospital, 07745 Jena, Germany.
Πηγή: Bioscience reports [Biosci Rep] 2026 Oct 21; Vol. 46 (10).
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 8102797 Publication Model: Print Cited Medium: Internet ISSN: 1573-4935 (Electronic) Linking ISSN: 01448463 NLM ISO Abbreviation: Biosci Rep Subsets: MEDLINE
Imprint Name(s): Publication: London : Portland Press on behalf of the Biochemical Society
Original Publication: London : The Biochemical Society, c1981-
Ιατρικοί όροι (MeSH): Thiophenes*/pharmacology , AMP-Activated Protein Kinases*/metabolism , Pyrones*/pharmacology , Endothelial Cells*/drug effects , Endothelial Cells*/enzymology , Enzyme Activators*/pharmacology , Resorcinols*/pharmacology, Enzyme Activation/drug effects ; Phosphorylation/drug effects ; Human Umbilical Vein Endothelial Cells/drug effects ; Humans ; Biphenyl Compounds
Περίληψη: AMP-activated protein kinase (AMPK), a heterotrimeric serine/threonine protein kinase consisting of the catalytic α-subunit and regulatory β- and γ-subunits, regulates endothelial homeostasis. Consequently, it has emerged as a target for pharmacological activators in the treatment of endothelial dysfunction. However, the efficiency of these agonists may differ depending on the expression of different AMPK subunit isoforms in different cells and tissues, as these isoforms may form AMPK complexes with distinct activation profiles. The present study compares the effects of three direct AMPK activators in endothelial cells: MK-8722, a pan-AMPK activator; SC4, an intermediate activator with preference for AMPKα2; and A-769662, a β1-specific compound. We demonstrate that MK-8722 (0.1 to 10 μM) induces a robust and sustained, short- and long-term activation of AMPK, as evidenced by the phosphorylation of acetyl-CoA carboxylase and the inhibition of the mechanistic target of rapamycin complex 1 pathway. On an equimolar basis, MK-8722 was significantly more potent than SC4 and A-769662. This was associated with a significant antiviral effect of MK-8722 against herpes simplex virus type 1, whereas SC4 and A-769662 had no effect. At 10 μM, MK-8722 led to energy depletion and increased formation of mitochondrial and cytosolic reactive oxygen species due to inhibition of mitochondrial complex I. Under these conditions, liver kinase B1-mediated AMPK activation was observed but was not functionally relevant. We propose that the strong activation of AMPK by MK-8722 is related to the presence of different AMPK heterotrimers in endothelial cells. Therefore, targeting endothelial dysfunction pharmacologically may require pan-AMPK activators.
(© 2026 The Author(s).)
References: Mol Cell Biol. 2006 Aug;26(16):5933-45. (PMID: 16880506)
Diabetes. 2002 Aug;51(8):2420-5. (PMID: 12145153)
Clin Chem. 2007 Apr;53(4):729-34. (PMID: 17332151)
Proc Soc Exp Biol Med. 1964 Mar;115:814-6. (PMID: 14155835)
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761. (PMID: 29155950)
Nat Rev Drug Discov. 2019 Jul;18(7):527-551. (PMID: 30867601)
Bioinformatics. 2014 Apr 1;30(7):923-30. (PMID: 24227677)
Cardiovasc Res. 2008 Oct 1;80(1):30-9. (PMID: 18710878)
Cell Metab. 2013 Oct 1;18(4):556-66. (PMID: 24093679)
Circ Res. 2017 May 26;120(11):1825-1841. (PMID: 28546359)
Science. 2017 Aug 4;357(6350):507-511. (PMID: 28705990)
Nucleic Acids Res. 2002 Jan 1;30(1):207-10. (PMID: 11752295)
Circ Res. 2009 Jul 17;105(2):114-27. (PMID: 19608989)
Methods Cell Biol. 2007;80:93-119. (PMID: 17445690)
Exp Mol Med. 2016 Apr 01;48:e224. (PMID: 27034026)
Cell. 2024 Sep 5;187(18):4833-4858. (PMID: 39241746)
Structure. 2014 Aug 5;22(8):1161-1172. (PMID: 25066137)
Methods. 2002 Apr;26(4):307-16. (PMID: 12054921)
Nat Commun. 2020 Aug 4;11(1):3881. (PMID: 32753572)
Mol Metab. 2024 Dec;90:102042. (PMID: 39362600)
Nat Rev Cardiol. 2025 Dec;22(12):923-943. (PMID: 40346347)
J Biol Chem. 1977 Dec 10;252(23):8731-9. (PMID: 925018)
J Cell Mol Med. 2022 Oct;26(19):4886-4903. (PMID: 36052760)
Biochem J. 1998 Aug 15;334 ( Pt 1):177-87. (PMID: 9693118)
Chem Biol. 2014 May 22;21(5):619-27. (PMID: 24746562)
Biochem Pharmacol. 2018 Jul;153:147-158. (PMID: 29408352)
Genes Dev. 2011 Sep 15;25(18):1895-908. (PMID: 21937710)
Cell Cycle. 2012 Mar 1;11(5):917-21. (PMID: 22333580)
ACS Med Chem Lett. 2017 Dec 01;9(1):39-44. (PMID: 29348809)
Mol Cell Biol. 2007 Jun;27(12):4317-27. (PMID: 17420279)
Cell Metab. 2019 Sep 3;30(3):414-433. (PMID: 31484054)
Cancer Med. 2013 Oct;2(5):611-24. (PMID: 24403227)
Nat Commun. 2013;4:3017. (PMID: 24352254)
Acta Physiol (Oxf). 2009 May;196(1):81-98. (PMID: 19245656)
Nature. 2008 Nov 6;456(7218):53-9. (PMID: 18987734)
Nat Rev Mol Cell Biol. 2023 Apr;24(4):255-272. (PMID: 36316383)
Cells. 2020 Mar 11;9(3):. (PMID: 32168879)
Chem Biol. 2012 Oct 26;19(10):1222-36. (PMID: 23102217)
Cells. 2024 Feb 24;13(5):. (PMID: 38474357)
J Immunol. 2020 Apr 1;204(7):1810-1824. (PMID: 32086387)
J Biol Chem. 2003 Aug 15;278(33):31000-6. (PMID: 12788940)
Genome Biol. 2013 Apr 25;14(4):R36. (PMID: 23618408)
Microbiol Spectr. 2023 Oct 17;11(5):e0041723. (PMID: 37702499)
Nat Metab. 2019 Mar;1(3):340-349. (PMID: 30887000)
Nat Rev Mol Cell Biol. 2018 Feb;19(2):121-135. (PMID: 28974774)
Biochem J. 2009 Jun 26;421(2):163-9. (PMID: 19442239)
J Biol Chem. 2007 Nov 9;282(45):32539-48. (PMID: 17728241)
Cell Chem Biol. 2018 Jun 21;25(6):728-737.e9. (PMID: 29657085)
J Biol Chem. 1991 Nov 5;266(31):20998-1003. (PMID: 1657942)
J Clin Invest. 2013 Jul;123(7):2764-72. (PMID: 23863634)
Biochem J. 2022 Jun 17;479(11):1181-1204. (PMID: 35552369)
Nat Med. 2018 Jul;24(7):1036-1046. (PMID: 29892070)
Mol Cell Biochem. 2025 Aug;480(8):4671-4695. (PMID: 40259179)
Biochem J. 2020 Sep 18;477(17):3453-3469. (PMID: 32869834)
Int J Mol Sci. 2024 May 31;25(11):. (PMID: 38892235)
Biochem J. 2017 Mar 7;474(6):983-1001. (PMID: 28008135)
J Biol Chem. 2010 Apr 2;285(14):10638-52. (PMID: 20129920)
Autophagy. 2016 Sep;12(9):1507-20. (PMID: 27305174)
Int J Obes (Lond). 2008 Sep;32 Suppl 4:S55-9. (PMID: 18719600)
Cell Metab. 2006 Jun;3(6):403-16. (PMID: 16753576)
Grant Information: N/A Deutsche Forschungsgemeinschaft (DFG); N/A Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF); N/A Interdisciplinary Center for Clinical Research (IZKF), Jena; N/A Landesgraduiertenstipendium of the Free State of Thuringia
Contributed Indexing: Keywords: A-769662; AMPK; AMPK activators; Endothelial cells; MK-8722; SC4
Substance Nomenclature: 0 (Thiophenes)
P68477CD2C (4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile)
EC 2.7.11.31 (AMP-Activated Protein Kinases)
0 (Pyrones)
0 (Biphenyl Compounds)
0 (Enzyme Activators)
0 (Resorcinols)
Entry Date(s): Date Created: 20260908 Date Completed: 20260922 Latest Revision: 20260925
Update Code: 20260925
PubMed Central ID: PMC13598317
DOI: 10.1042/BSR20250408
PMID: 42708818
Βάση Δεδομένων: MEDLINE